Global Pharmaceuticals & Biotech Breakout Stocks

Amylyx Pharmaceuticals

Market Cap: US$2.4b

A clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States.

Eton Pharmaceuticals

Market Cap: US$1.8b

A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.

HARBIN GLORIA PHARMACEUTICALS

Market Cap: CN¥10.6b

Engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China and internationally.

Omeros

Market Cap: US$1.3b

A clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases.

Kura Oncology

Market Cap: US$1.1b

A clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer.

Climb Bio

Market Cap: US$1.0b

A clinical-stage biotechnology company, focuses on developing therapies to address unmet needs for patients living with immune-mediated diseases.

Boji Medical TechnologyLtd

Market Cap: CN¥6.4b

Provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally.

Gansu Longshenrongfa Pharmaceutical IndustryLTD

Market Cap: CN¥5.9b

Researches, develops, produces, and sells traditional Chinese medicines, medical devices, and health products in China and internationally.

4D Molecular Therapeutics

Market Cap: US$814.3m

A late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States.

Oncolys BioPharma

Market Cap: JP¥104.3b

Engages in the research, development, manufacturing, sale, and import of oncolytic viruses, drugs and medicines, and tumor diagnostic agents in Japan, the United States, and Asia.

Shanghai Kai Kai Industry

Market Cap: CN¥4.1b

Engages in the wholesale and retail of pharmaceutical products in China.

Shanghai Shenqi Pharmaceutical Investment Management

Market Cap: CN¥3.9b

Operates as a pharmaceutical manufacturing holding investment company in China.

Xinjiang Tianshan Animal Husbandry Bio-engineering

Market Cap: CN¥3.1b

Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd.

Ind-Swift Laboratories

Market Cap: ₹30.2b

Develops, manufactures, and sells active pharmaceutical ingredients (APIs), intermediates, and formulations in India and internationally.

AVITA Medical

Market Cap: US$244.3m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

Cardiol Therapeutics

Market Cap: CA$290.9m

A clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.

NeOnc Technologies Holdings

Market Cap: US$122.0m

A clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies.

Helix BioPharma

Market Cap: CA$154.3m

A clinical-stage biopharmaceutical company developing therapies in the field of immune-oncology in Canada.

Sareum Holdings

Market Cap: UK£40.2m

A clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases.

Apollomics

Market Cap: US$52.5m

A clinical-stage biopharmaceutical company, engages in the discovery and development of oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer.

Valiant Laboratories

Market Cap: ₹4.9b

Operates as an active pharmaceutical ingredient/bulk drug manufacturing company in India and internationally.

BetterLife Pharma

Market Cap: US$33.5m

A biotechnology company, engages in the development of psychedelic-derived compounds.

Bilcare

Market Cap: ₹2.5b

Provides pharmaceutical packaging research solutions in India and internationally.

Aton

Market Cap: €13.9m

Operates as a bioscience company in France.

Intravenous Infusions

Market Cap: GH₵137.2m

A pharmaceutical company, engages in the manufacturing and marketing of intravenous infusions and small volume injectables for therapeutic purposes in Ghana and the West African sub-region.

Brainstorm Cell Therapeutics

Market Cap: US$12.0m

A biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases.

Dannex Ayrton Starwin

Market Cap: GH₵75.4m

Engages in the manufacturing, importing, and sale of pharmaceutical products in Ghana.

1933 Industries

Market Cap: CA$5.2m

Engages in the cultivation, extraction, and production of cannabis products in the United States.

Enzolytics

Market Cap: US$2.9m

A drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases.

Vaccinex

Market Cap: US$2.1m

A clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders.

PAO Group

Market Cap: US$191.0k

Focuses on alternative patient care treatments.

Hero Technologies

Market Cap: US$56.4k

Operates as an early-stage cannabis company.

EVIO

Market Cap: US$20.7k

Provides analytical testing and advisory services to the cannabis industry.

Vaxxinity

Market Cap: US$12.7k

A biotechnology company, focuses on developing product candidates for human use in the fields of neurology, cardiovascular diseases, and coronaviruses in the United States.

ObsEva

Market Cap: US$11.7k

A biopharmaceutical company, focuses on the development of novel therapies to improve women’s reproductive health.

CBD of Denver

Market Cap: US$10.7k

Engages in developing and commercializing cannabidiol (CBD) products.